Fresh analysis indicates that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt conventional lifestyle programs.
Findings released in a leading health publication points out that while obese people often shed substantial amounts of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying such treatments must be informed of the potential of fast weight regain when the medication concludes," stated researcher Dr. Susan Jebb.
This pace of recovery implies a return to original weight within about one and a half years.
Analyzing Therapies
The analysis, which reviewed dozens of studies involving thousands of patients, compared the results of GLP-1 agonists with older methods.
The team emphasize that people who lose weight through dieting generally experience a slower creep back—approximately 0.1 kg a month—after stopping.
Explaining the Quick Regain
Experts believe the way of the injections is key to understanding the heightened weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone levels several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' results in hunger is uncontrolled, making excessive eating much more probable."
A Lifelong Disease?
The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts argue that, due to the likelihood of weight regain, the treatment is often life-long.
This opinion is supported by drug manufacturers, who note that the results "underscore the chronic nature of obesity," similar to managing conditions like diabetes.
User Testimonies
Users who have discontinued the jabs explain a sudden return of appetite.
"It felt as if a switch flipping and you're instantly ravenous," said an individual.
This challenge is worsened if patients have not adopted lasting lifestyle or habit modifications during therapy.
Significant Interest
Figures indicate that millions of people in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Adoption is more common among females compared to men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, researchers emphasize that while the jabs are powerful agents for shedding pounds, they are not a permanent fix and maintained weight loss hinges on combined behavioural support.
